Chan, K. A.(2000). Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 355: 2185-8.
Reid, I. R.(2001). Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet 357: 509-12.
Wang, P. S.(2000). HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. Jama 283: 3211-6.
Meier, C. R.(2000). HMG-CoA reductase inhibitors and the risk of fractures. Jama 283: 3205-10.
van Staa, T. P.(2001). Use of statins and risk of fractures. Jama 285: 1850-5.
Cummings, S. R.(2000). Do statins prevent both cardiovascular disease and fracture? Jama 283: 3255-7.
Chung, Y. S.(2000). HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 85: 1137-42.
Wada, Y.(2000). Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes. Arch Intern Med 160: 2865.
Mundy, G.(1999). Stimulation of bone formation in vitro and in rodents by statins. Science 286(5446): 1946-9.
Sugiyama, M.(2000). Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271: 688-92.
Sato, T.(1998). Involvement of cholesterol in osteoclast-like cell formation via cellular fusion. Bone 23(2): 135-40.
Bassa, B. V.(1999). Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells. Biochim Biophys Acta 1449(2): 137-49.
van beek, E.(1999). The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates. J Bone Miner Res 14(5): 722-9.
Fisher, J. E.(1999). Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A 96(1): 133-8.
Luckman, S. P.(1998). Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13(4): 581-9.